HEOR Archives -

NICE backs broad use for Gilead/Galapagos arthritis pill Jyseleca

https://pharmaphorum.com/news/nice-backs-broad-use-for-gilead-galapagos-arthritis-pill-jyseleca/

Scotland backs Roche’s Rozlytrek for ROS1 lung cancer

https://pharmaphorum.com/news/scotland-backs-roches-rozlytrek-for-ntrk-tumours/

NICE backs AZ’s Forxiga for heart failure

https://pharmaphorum.com/news/nice-backs-azs-forxiga-for-heart-failure/

Okra says AI-based drug price predictor is 90% accurate

https://pharmaphorum.com/news/okra-ai-based-drug-price-predictor-90-accurate/

Gene Therapy Medical Affairs

https://pharmaphorum.com/events/gene-therapy-medical-affairs/

KANTAR HEALTH’S JESSICA SANTOS TO RECEIVE ISPOR SERVICE AWARD

https://pharmaphorum.com/partner-content/kantar-healths-jessica-santos-to-receive-ispor-service-award/

Web and mobile technologies for health economics modelling

https://pharmaphorum.com/views-and-analysis/web-mobile-technologies-health-economics-modelling/

Available on demand: Cancer Treatment Access: Strategy, Approach, Outcomes

https://pharmaphorum.com/debates-insight-oncology/cancer-treatment-access-strategy-approach-outcomes/

Search